August 2007:
August 27th:
New Funding For Clinical Trial Using BrainZ Technology
read article >
August 21st:
CogState Signs Agreement for Phase IV Trial with Pfizer
read article >
August 21st:
Bone Medical Approval To Start Phase I/IIa Trial For Second Osteoporosis Drug Ethics Approval For Queensland Human Trial
read article >
August 21st:
Benitec Appoints Chief Scientific Officer
read article >
August 17th:
Stem Cell Storage Service Connected With Potential Benitec HIV Drug Therapy
read article >
August 16th:
Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
read article >
August 16th:
HealthLinx Begins Ovarian Cancer Diagnostic Phase II Biomarker Trial
read article >
August 14th:
Metabolic Discontinues Clinical Trial Programme For Neuropathic Pain Drug, ACV1
read article >
August 13th:
Rockeby And National University of Singapore Awarded EDB Grant To Develop Rapid Diagnostic Test For Hand, Foot and Mouth Disease
read article >
August 7th:
HalcyGen Begins Second Study of Anti-fungal Drug
read article >
August 7th:
ChemGenex to Present at Canaccord Adams' 27th Global Growth Conference
read article >
August 6th:
Bionomics To Develop Cancer Drug Target Target BN069 With Support From The Cancer Therapeutics CRC
read article >
August 6th:
Anadis and ImmuCell to Cross-License Antibody Technologies
read article >
August 1st:
Bone Medical's Capsitonin Study Shows Capsule Is As Effective As Nasal Version
read article >
August 1st:
Acrux Estradiol Spray Approved By FDA
read article >
|
